Supernus Pharmaceuticals, Inc. (SUPN)
51.35
+0.17
(+0.33%)
USD |
NASDAQ |
Feb 11, 16:00
51.35
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Price : 51.35 for Feb. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Biogen, Inc. | 191.23 |
| Catalyst Pharmaceuticals, Inc. | 23.94 |
| Vertex Pharmaceuticals, Inc. | 461.21 |
| Krystal Biotech, Inc. | 272.32 |
| Moderna, Inc. | 40.49 |
Price Related Metrics
| PS Ratio | 4.248 |
| Price to Book Value | 2.805 |
| Price to Free Cash Flow | 40.92 |
| Earnings Yield | -0.66% |
| Market Cap | 2.944B |